Abstract
Hypoactive sexual desire is a common complaint in men of all ages. By recognizing different etiologies that contribute to low libido in men, clinicians can initiate a patient-centered evaluation and treatment plan. A thorough history, physical exam, and appropriate laboratory investigations can identify men with underlying medical and/or psychiatric conditions that can be addressed to improve sexual desire. Men without modifiable comorbid conditions represent a current challenge, as there are no treatments specific to male hypoactive sexual desire. As the understanding of male hypoactive sexual desire evolves, more modalities will become available for both assessment and treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Just as an example, see the definition of libido in a psychoanalytical online resource: Libido: the psychosexual energy originating in the id. Libido is the electric current of the mechanism of personality. It powers all psychological operations, invests desires, and undergoes ready displacement. It is the basic fuel of the self. Because it is of a relatively fixed quantity, like gasoline in a tank, it obeys laws of psychical “economy” in that a surplus in one system means a loss somewhere else. It can be either free or bound.
References
Rubio-Aurioles R. Hypoactive sexual desire on men. In: Porst H, Buvat J, The Standards Committee of the International Society for Sexual Medicine, editors. Standard practice in sexual medicine. Malden, MA: Blackwell Publishing; 2006. p. 149–57.
Levine SB. Hypoactive sexual desire disorder in men: basic types, causes, and treatment. Psychiatr Times. 2010;27:40–3.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in “normal” couples. N Engl J Med. 1978;299:111–5.
Laumann EO, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.
Mercer CH, Fenton KA, Johnson AM, Wellings K, Macdowall W, McManus S, Nanchahal K, Erens B. Sexual function problems and help seeking behavior in Britain: national probability sample survey. BMJ. 2003;327:426–7.
Najman JM, Dunne MP, Boyle FM, Cook MD, Purdie DM. Sexual dysfunction in the Australian population. Aust Fam Physician. 2003;32:951–4.
Fugl-Meyer AR, Fugl-Meyer KS. Sexual disabilities, problems, and satisfactions in 18–74 year old Swedes. Scand J Sexol. 1999;2:79–105.
Laumann E, Glasser DB, Neves RCS, Moreira EDJ, GSSAB Investigators Group. A population-based survey of sexual activity, sexual problems and associated help seeking behavior patterns in mature adults in the United States of American. Int J Impot Res. 2009;21:171–8.
Bancroft J. Sexual desire and the brain. J Sex Marital Ther. 1988;3:11–27.
Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol. 2005;63:381–94.
Zitzman M, Farber S, Nieschlang E. Association of specific symptoms and metabolic risk with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91:4335–43.
De Rosa M, Zarrilli S, Vitale G, Di Somma C, Orio F, Tauchmanova L, Lombardi G, Colao A. Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. J Clin Endocrinol Metab. 2004;89:621–5.
Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res. 2003;15:373–7.
Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989;12:375–83.
Bancroft J, Janssen E, Strong D, Carnes L, Vukadinovic Z, Long JS. The relation between mood and sexuality in heterosexual men. Arch Sex Behav. 2003;32:217–30.
Kennedy SH, Dickens SE, Eisfeld BS, Bagbya RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord. 1999;56:201–8.
Corona G, Petrone L, Mannucci E, Ricca V, Balercia G, Giommi R, Forti G, Maggi M. The impotent couple: low desire. Int J Androl. 2005;28:46–52.
Casper RC, Redmond E, Katz MM, et al. Somatic symptoms in primary affective disorders: presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985;42:1098–104.
Meuleman E, Van Lankveld J. Hypoactive sexual desire disorder: an underestimated condition in men. Presented at University Medical Centre St Radboud and Pompekliniek, Nijmegen; 12 July 2004.
Nilsson P, Moller L, Solstad K. Adverse effects of psychosocial stress on gonadal function and insulin levels in middle-aged males. J Intern Med. 1995;237:479–86.
Aubin S, Berger RE, Herman JR, Ciol MA. The association between sexual function, pain, and psychological adaptation of men diagnosed with chronic pelvic pain syndrome type III. J Sex Med. 2008;5:657–67.
Laumann EO, Nicolosi A, Glasser DB, Paik A, Ginge C, Moreira E, Wang T. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res. 2005;17:39–57.
Schiavi RC, Rehman J. Sexuality and aging. Urol Clin N Am. 1995;22:711–26.
Tessler Lindau S, Schumm L, Laumann E, Levinson W, O’Muircheartaigh A, Waite L. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762–74.
Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr. 2002;30:187–90.
Crenshaw TL, Goldberg JP. Sexual pharmacology: drugs that affect sexual functioning. New York: W. W. Norton and Company; 1996.
Gutierrez MA, Stimmel GL. Management of and Counseling for psychotropic drug-induced sexual dysfunction. Pharmacotherapy. 1999;19(7):823–31. See more at http://www.pharmacytimes.com/publications/issue/2010/June2010/LossofLibido-0610#sthash.ZAXPTnWT.dpuf
Frye CB, Berger JE. Treatment of sexual dysfunction induced by selective serotonin-reuptake inhibitors. Am J Health Syst Pharm. 1998;55:1167–9.
Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther. 1997;61:476–87.
Guthrie SK. Clinical issues associated with maintenance treatment of patients with schizophrenia. Am J Health Syst Pharm. 2002;59 Suppl 5:S19–24.
Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry. 1989;46:275–84.
Reis R, Goncalves A, Sakamoto A, Ferriani R, Lara L. Altered sexual and reproductive functions in epileptic men taking carbamazepine. J Sex Med. 2013;10:493–9.
Wincze JP, Carey MP. Sexual dysfunction: a guide for assessment and treatment. 2nd ed. New York: Guilford Press; 2001.
Bozman AW, Beck JG. Covariation of sexual desire and sexual arousal: the effects of anger and anxiety. Arch Sex Behav. 1991;20:47–60.
Kaplan HS. Disorders of sexual desire. New York: Brunner/Mazel; 1979.
DeRogatis L, Rosen R, Goldstein I, Werneburg B, Kempthorne-Rawson J, Sand M. Characterization of hypoactive sexual desire disorder (HSDD) in men. J Sex Med. 2012;9(3):812–20.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.
Spector IP, Carey MP, Steinberg L. The sexual desire inventory: development, factor structure, and evidence of reliability. J Sex Marital Ther. 1996;22:175–90.
Clayton AH, Goldfischer ER, Goldstein I, DeRogatis L, Lewis-D’Agostino DJ, Pyke R. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med. 2009;6:730–8.
American Association of Clinical Endocrinologist. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple’s problem—2003 update. Endocr Pract. 2003;9:77–95.
Masters WH, Johnson VE. Human sexual response. Boston: Little, Brown and Co.; 1966.
Trudel G, Marchand A, Ravart M, et al. The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sex Relat Ther. 2001;16:145–64.
Morales A, Heaton JP. Hormonal erectile dysfunction. Evaluation and management. Urol Clin N Am. 2001;28:279–88.
O’Carroll R, Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry. 1984;145:146–51.
Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ. Metabolic and behavioral effects of high-dose exogenous testosterone in healthy men. J Clin Endocrinol Metab. 1994;79:561–7.
Bloch M, Meiboom H, Zaig I, Schreiber S, Abramov L. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differenced. Eur Neuropsychopharmacol. 2013;239(8):910–8.
Segraves R, Clayton A, Croft H, et al. Bupropion sustained release for the treatment of sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;3:339–42.
Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): results from a randomized withdrawal trial. J Sex Med. 2011;8(11):3160–72.
Fabre LF, Brown CS, Smith LC, Derogatis LR. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women. J Sex Med. 2011;8:1411–9.
Fabre L, Clayton A, Smith L, Goldstein I, Derogatis L. The effect of Gepirone-ER in the treatment of sexual dysfunction in depressed men. J Sex Med. 2012;9:821–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Commentary: Hypoactive Sexual Desire in Men
Hypoactive sexual desire disorder in males represents a diagnostic and therapeutic challenge to both clinicians and mental health specialists. The number of affected men is striking and highlights the need for a better understanding of decreased sexual desire in men. Diagnostically, the subjective nature of sexual desire and the absence of validated instruments to aid diagnosis specifically in men can limit accurate identification of affected men, particularly in the presence of other confounding conditions such as depression or anxiety. Thus, it is imperative that the workup thoroughly assess for conditions that can result in the patient’s symptoms. The preceding chapter discusses the physiology of low sexual interest in men, as well as conditions that may predispose to decreased sexual interest. Segueing then into evaluation and treatment, Krakowsky and Grober acknowledge the diagnostic challenge inherent in identifying low sexual desire in men and discuss the role of psychotherapy, as well as limited pharmacotherapy, in the treatment of this condition.
Expanding on the discussion of the role of psychotherapy in low sexual desire in men, the following commentary focuses on the role of dual-control models in sexual function. Such models incorporate both excitatory and inhibitory factors in explaining sexual dysfunctions, providing a basis for understanding the impact of various factors and interventions. Diving more deeply into the psychological underpinnings of low sexual desire and using case vignettes, Rubio-Aurioles highlights an integrated approach to men with decreased sexual desire, marrying psycho- and pharmacotherapy.
The Editors
Commentary
Sexual problems in general and sexual dysfunctions in particular present a challenge to the clinician who still operates with the duality of mind-body imposed in medicine some years ago. The intertwining of factors that originated in the biological processes of the body with factors of a so-called “mental” nature is so pervasive in the reality of clinical practice that the ideal of an integral approach is an imperative when the assessment of a specific sexual problem is in order.
In the case of sexual desire, the above consideration is even more critical. Sexual desire is an elusive and mysterious experience for many people, yet it is considered one of the main motivators in life. The elusive nature of sexual desire is fairly evident for the man, who after having decided to marry the “perfect candidate” loses his desire for sexual interaction with her with absolutely no clue as to why his desire remains vivid, but not for his wife.
The problems surrounding sexual desire for clinicians begin with the diagnosis of the condition. “Low libido,” “hypoactive sexual desire disorder,” and “lack of interest in sex” are terms used to describe this clinical problem [1]. Libido refers to the Freudian construct of drive, and its use, although generalized, does not give honor to the original ideas of what libido [2] was supposed to be.Footnote 1 Hypoactive sexual desire makes reference to the inclusion in the 1980s [2] of the condition initially called inhibited sexual desire and then modified to hypoactive sexual desire disorder in the classification of mental disorders. The problem with these terms is that they refer to a condition that actually excludes most of the patients presenting with the complaint of low or absent sexual desire due to depression, hormonal problems, and relationship issues that should not be present for a diagnosis of hypoactive sexual desire disorder to be made. Another problem is that the term “desire” is not always understood or interpreted uniformly; the term “sexual interest” has been suggested in its stead [3]. In my opinion, the use of the term “low sexual desire/interest” facilitates the frame of mind needed in the clinical setting to address this condition [4].
The Psychological Factors in Low Sexual Desire
In the last several years, a number of models have been proposed to explain variations in sexual desire/interest. Several of these models can be grouped under the term “dual-control models,” which serve to synthesize activating and inhibiting components involved in sexual desire.
Helen Kaplan [5], who devoted considerable time and effort to conceptualize sexual desire problems as a distinct sexual dysfunction, organized factors that produce the experience of lust as sexual incentives and sexual suppressors or inhibitors, both of a physiological and a psychological nature. Among the psychological inhibitors of desire Kaplan enumerates are partner unattractive, negative thoughts, anti-fantasies, negative emotions, and stress and anger. Some time later, John Bancroft [6] proposed a model named the dual-control model that is supported by psychosocial research where inhibitory processes are considered “active processes.” These inhibitory processes serve either functional purposes, such as the inhibition of sexual activity when there is real danger or threat, or dysfunctional ones, such as situations in which there is only perceived danger or when the individual has a “high inhibitory tone.” Michael Perelman organized these ideas in a model called the Sexual Tipping Point (TM) Model [7]. The model proposes that a balance between pro and con factors results in activation or deactivation of the sexual experience; the lack or deficit in desire/interest would be the result of the predominance of inhibitory processes over excitatory ones (Fig. 16.3).
Several of these ideas have been tested empirically. Bozman and Beck [8, 9] studied the effects of anger and anxiety on sexual desire and sexual arousal and found that these emotional states reduce sexual desire. More recently, Carvalho and Nobre [10] tested an integrative model of biopsychosocial determinants of men’s sexual desire using sophisticated statistical techniques (path analysis) to assess the relationships between several psychological variables and the level of sexual desire. Their investigation supports the previous elaborations offered by clinicians and researchers but shows that for some of the variables traditionally related to low sexual desire, such as dyadic adjustment, the effect is not as important as, for instance, the lack of erotic thoughts and erectile concerns (Fig. 16.4).
Psychological Etiologies in Low Sexual Desire of Men
Krakowsky and Grober have presented the array of possible etiological processes in detail in the preceding chapter. Psychological or mental processes are often involved when a man complains of low sexual desire. Figure 16.5 presents an algorithm for diagnosis and shows the processes where psychological considerations are critical, although the psychological impact of the condition is almost always present, regardless of the etiological process (Fig. 16.5).
Case Examples
The following clinical vignettes present typical situations where the psychological factors are predominant in men seeking consultation for low sexual desire/interest.
5.1 Depression, Anxiety, and Chronic Stress
David, 44 years of age, was an executive from a big accounting firm. He recently lost his job after a large illegal transaction was discovered; he has been looking for a new position for 10 months unsuccessfully. He explains that his wife, who is a successful public relations manager in a big pharma company, told him that the situation in their intimacy is no longer acceptable and that either he finds a solution for his lack of interest in sexual intimacy or they were going to divorce. He accepts that his desire and interest in sexual activity has disappeared and indicates that no other sexual partners exist and that he has been faithful during the 10 years of marriage which he considers otherwise very good. David considers himself to be in good health, with no medical history of relevance. His erectile function is normal according to the SHIM questionnaire. Basic laboratory studies including testosterone, prolactin, and TSH are normal.
Depression can impair sexual desire, as it is one of the frequent symptoms that accompany this medical condition. Depressive illness can be easily identified with two questions [11]; a “no” response to these two questions makes it highly unlikely for the man to have a depression:
-
During the past month, have you often been bothered by feeling down, depressed, or helpless?
-
During the past month, have you often been bothered by little interest or pleasure in doing things?
If the initial clinical impression of depressive illness is confirmed, proper treatment and consideration of referral to a mental health specialist is in order.
The impact of depression in the health of the relationship is clear in this example. The partner of a man with low desire feels rejection, and this can be the beginning of a new problem as the relationship deteriorates. Usually, healthy partners are direct in their communication and frequently request their male partners with low desire to address the issue directly.
Treatment of depression represents still another challenge, as most antidepressants have a negative impact on sexual desire. However, to treat the depressive illness is critical for the recovery of health; a clear explanation of the next steps during treatment is helpful and much better if the partner is present in the consultation.
5.2 Relationship Conflict
Jose, 50 years of age, is a successful entrepreneur that runs a construction company that was started by him 20 years ago. His first marriage lasted 15 years and ended because of multiple disagreements regarding the time Jose devoted to family and work. Three years ago he initiated a new relationship with a young and attractive woman who treated him very well and after a year moved in with Jose, who lived alone before that. As the couple stared their cohabitation, his desire for sexual interaction started to diminish. As the relationship progressed, her economic demands increased. In addition, significant arguments revolving the amount of money allotted to the first wife by the divorce agreement and requests to help her family have been pervasive. Jose recognizes the beauty and initial attraction and would like to find ways to repair his current relationship as he considers a second failure impossible to bear. There has been no sexual interaction during the last 6 months. Jose masturbates when she is not around with no problems and with fantasies of different women. Basic laboratory studies, including testosterone, prolactin, and TSH levels, are normal.
Many men experience difficulties with their sexual desire when the environment in the relationship turns hostile. Identifying the conflict in a relationship is easy when this is explicit, but sometimes this is not the case.
Conflict with the sexual partner is a long recognized etiology of secondary and selective (specific to the partner) low sexual desire [12]. Conflict in relationships is easy to identify if the right questions are asked. Sometimes asking directly about the quality of the relationship will provide enough information. The questions presented below can provide good clinical information about the quality of the relationship. Although they were developed in a research setting, these questions provide good guidance on what to investigate when a couple is being evaluated [13]:
-
Do you and your partner agree or disagree on displays of affection?
-
Do you often think about getting a divorce or separation or ending your current relationship?
-
In general, would you say that everything is fine between you and your partner?
-
Do you confide in your partner?
-
Do you ever regret getting married (or living together)?
-
How many times do you and your partner calmly discuss something?
-
How many times do you and your partner work together in something?
-
Circle the number that best corresponds to your level of happiness as a couple (rate between 1 and 7, 7 being perfectly happy).
5.3 Male Hypoactive Sexual Desire Disorder
Victor is a 35-year-old professor at a recognized university. He has been dedicated to his career and academic advance, and his efforts have culminated in international recognition and a good number of publications. Three years ago he decided to start a formal relationship with a former student, who is now a promising professor at the same university. They decided to marry 2 years ago. He and his partner, who presents herself to the consultation, consider their marriage as very good with the exception of the almost nonexistent sexual life. Victor had a depressive episode when he was 17 years old after the passing of his mother; he recognizes the depressive illness and gives assurance during the consultation that he is not depressed now. When sexual interaction occurs, it is highly pleasurable for both, with no problems with the erection, lubrication, and easiness of orgasm and ejaculation control. Basic laboratory studies, including testosterone, prolactin, and TSH, are normal.
Low sexual desire, in the absence of medical and psychosocial factors that could otherwise explain it, is referred to as male hypoactive sexual desire disorder. A recent report characterized these men [14], who have been shown to have differences in the pattern of activation in response to sexual stimuli [15].
Identifying these patients is essential in directing therapeutic interventions more efficiently.
Treatment Approaches for the Psychological Factors in Low Sexual Desire
6.1 Treatment of Low Sexual Desire Secondary to Depressive Illness and/or Anxiety Disorder
Major depression is associated with decreased sexual interest in >40 % of men [16]. Treatment of depression should include the use of pharmacotherapy. While many of the medications used to treat depression impact sexual function, antidepressants that have less impact on sexual function include mirtazapine, bupropion, and the serotonin-norepinephrine reuptake inhibitors venlafaxine and duloxetine [17, 18]. There is ample evidence that the combination of pharmaco- and psychotherapy improves the efficacy of the treatment of depression [19]; therefore, such combinations should be provided whenever possible.
Several anxiety disorders might be related to low sexual desire, among them: posttraumatic stress disorder, acute stress disorder, and generalized anxiety disorder. Identification and proper treatment of these conditions might be critical for the management of low sexual desire [20].
6.2 Treatment of Low Sexual Desire Secondary to Relationship Conflict
Conflict and relationship distress may cause low sexual desire; when this factor is encountered, the patient and his partner should be referred to couple/relationship therapy (sometimes called marital therapy), a specialized form of psychotherapy that has proven efficacy in addressing couple distress [21]. Although reports on the application of couple therapy to low sexual desire are still anecdotal [22], clinical experience suggests this approach is sensible and effective. Sometimes, troubled relationships benefit from relatively simple interventions. Straightforward, small changes in couple dynamics can improve partner interaction for some couples, and such “treatment” can be performed in the primary care setting. Examples include the use of open communication on sexual issues with an open and honest approach, more time dedicated to physical intimacy and to talking about intimacy issues and sharing of feelings [23]. Severe conflict should be referred to a specialized professional.
Treatment of Male Hypoactive Sexual Desire Disorder
There are two possible approaches to the treatment of male hypoactive sexual desire disorder: pharmacological approaches and psychotherapeutic approaches. Regarding pharmacological approaches, there are no effective symptomatic treatments as there are for other sexual dysfunctions such as erectile dysfunction (i.e., phosphodiesterase type 5 inhibitors). Bupropion, an antidepressant that affects reuptake of dopamine and norepinephrine [24], has been studied and has shown a modest effect on women [25, 26]. Flibanserin, an agonist/antagonist of serotonin receptors, has shown efficacy in treating hypoactive sexual desire disorder (HSDD) in premenopausal women in several studies [27]. Although no reports of its efficacy in men with HSDD exist, flibanserin has the potential for possible benefit. Current experience is only in research settings as flibanserin has not yet been approved in any country.
Specific psychotherapeutic interventions for hypoactive sexual desire disorder have the following components [17]: affectual awareness that strives to identify positive and negative emotions related to sexual interaction and desire; insight and understanding, where a framework to understand the problem is offered to the patient; cognitive and systemic therapy, when individual psychological causes are addressed and interaction factors are addressed and corrected; and, finally, behavioral intervention, where a number of strategies are utilized to gradually overcome obstacles to sexual interaction.
Psychosexual therapy has developed approaches to treat hypoactive sexual desire in men, combining the classical interventions designed by Masters and Johnson [28] with more integrated psychodynamic and systemic interventions developed by Helen Kaplan in her classical approach to psychosexual therapy [6]. In short, these procedures involve the use of prescribed sequences of progressively more integrated and complex sexual behaviors for the patient to engage with his partner (or during self-stimulation with structured fantasies) and a variety of psychotherapeutic interventions including interpretation, confrontation, and restructuring of the couple interaction to address the more unconscious processes that are considered to block the experience of sexual desire.
Conclusion
Low sexual desire is a common complaint that has several etiologies. Investigating all levels of possible causality is critical for success in clinical management of this condition. The psychological factors are highly prevalent, and the clinician addressing this important area of health with patients should include an integrated and holistic approach to adequately evaluate and treat men with low sexual desire.
References
-
1.
Chalquist C. A glossary of Freudian terms: http://www.terrapsych.com/freud.html, consulted on 21 Dec 2014.
-
2.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM.III). 3rd ed. American Psychiatric Association; 1980.
-
3.
Fugl-Meyer KS, Lewis RW, Corona G, Hayes RD, Laumann EO, Moreira ED, Rellini AH, Segraves T. Definitions, classification, and epidemiology of sexual dysfunction. In: Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano F, Khoury S, Sharlip I, editors. Sexual medicine sexual dysfunctions in men and women: 3rd international consultation on sexual medicine. Paris: Health Publication Ltd; 2010. p. 41–117.
-
4.
Rubio-Aurioles E, Bivalacqua TJ. Standard operational procedures for low sexual desire in men. J Sex Med. 2013;10:94–107.
-
5.
Kaplan HS. The sexual desire disorders: dysfunctional regulation of sexual motivation. New York: Brunner/Mazel; 1995.
-
6.
Bancroft J. Central inhibition of sexual response in the male: a theoretical perspective. Neurosci Biobehav Rev. 1999;23:763–84.
-
7.
Perelman MA. The sexual tipping point: a model to conceptualize etiology, diagnosis and combination treatment of female and male sexual dysfunction. J Sex Med. 2006;3(1 suppl):52. Abstract 121.
-
8.
Bosman AW, Beck JG. Covariation of sexual desire and sexual arousal: the effects of anger and anxiety. Arch Sex Behav. 1991;20(1):47–60.
-
9.
Beck JG. Bosman AW. Gender differences in sexual desire: the effects of anger and anxiety. Arch Sex Behav. 1995;24(6):47–60.
-
10.
Carvalho J, Nobre P. Biopsychosocial determinants of men’s sexual desire: testing an integrative model. J Sex Med. 2011;8:754–763.
-
11.
Whooley M, Avins A, Miranda J, Browner W. Case finding instruments for depression: two questions are as good as many. J Gen Intern Med. 1997;12:439–45.
-
12.
Levine SB. Hypoactive sexual desire disorder in men: basic types, causes, and treatment. Psychiatr Times. 2010;27:40–3.
-
13.
Begin C, Sabourin M, Bovin E. Frénetté. Paradis. The couple—Part 1—Couple distress factors associated with evaluating the spousal relationship. In: Quebec Longitudinal Study of Child Development (QLSCD 1998–2002) from birth to 29 months, vol 2, issue 11. Québec: Institut de la statistique du Québec; 2002.
-
14.
DeRogatis L, Rosen RC, Goldstein I, Werneburg B, Kempthorne-Rawson J, and Sand M. Characterization of hypoactive sexual desire disorder (HSDD) in men. J Sex Med. 2012;9:812–20.
-
15.
Stoléru S, Redouté J, Costes N, Lavenne F, Le Barsb D, Dechaud H, Forest MG, Pugeat M, Cinotti L, Pujol JF. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder. Psychiatry Res. 2003;124:67–86.
-
16.
Pridal CG, Lopiccolo J. Multi-element treatment of desire disorders: integration of cognitive, behavioral, and systemic therapy. In: Leiblum SR, Rosen RC, editors. Principles and practice of sex therapy. 3rd ed. New York: The Guilford Press; 2000.
-
17.
Clayton A, Keller A, McGarvey E. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord. 2006;91:27–32.
-
18.
Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med. 2007;4:917–29.
-
19.
Cuijpers P, van Straten A, Hollon SD, Andersson G. The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression: a meta-analysis. Acta Psychiatr Scand. 2010;121:415–23.
-
20.
Corretti G, Baldi I. The relationship between anxiety disorders and sexual dysfunction. Psychiatr Times. 2007;24:1–7.
-
21.
Klann N, Hahlweg K, Baucom DH, Kroeger C. The effectiveness of couple therapy in Germany: a replication study. J Marital Fam Ther. 2011;37:200–8.
-
22.
Gehring D. Couple therapy for low sexual desire: a systemic approach. J Sex Marital Ther. 2003;29:25–38.
-
23.
Rosen RC. Psychogenic erectile dysfunction. Classification and management. Urol Clin N Am. 2001;28:269–78.
-
24.
Ferris RM, Cooper BR, Maxwell RA. Studies of bupropion’s mechanism of antidepressant activity. J Clin Psychiatry. 1983;44:74–8.
-
25.
Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther. 2001;27:303–16.
-
26.
Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;24:339–42.
-
27.
Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): results from a randomized withdrawal trial. J Sex Med. 2011;8:3160–70.
-
28.
Masters WH, Johnson V. Human sexual inadequacy. Boston: Little Brown; 1970.
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krakowsky, Y., Grober, E.D. (2016). Hypoactive Sexual Desire in Men. In: Lipshultz, L., Pastuszak, A., Goldstein, A., Giraldi, A., Perelman, M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3100-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3100-2_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3099-9
Online ISBN: 978-1-4939-3100-2
eBook Packages: MedicineMedicine (R0)